Influenza drug shows promise against SARS-CoV-2

Researchers have found that high doses of a drug called favipiravir strongly inhibit SARS-CoV-2 in hamsters. Favipiravir also prevented infection in healthy animals that had exposure to an infected cage mate. It takes many years to develop a potent antiviral drug from scratch for a particular viral infection. Throughout the pandemic of COVID-19 — the […]

SARS-CoV-2 may be able infect significant number of mammals

New research suggests that a significant number of mammals could be susceptible to infection with SARS-CoV-2. A new study has found that SARS-CoV-2 could theoretically infect a large number of mammals. The research, which appears in the journal Scientific Reports,...

Could a novel UV light device inactivate SARS-CoV-2 on surfaces?

Physicists have found a way to make powerful UV LEDs that they believe manufacturers could incorporate into lightweight devices for destroying pathogens such as the new coronavirus. Share on PinterestAn innovative device that emits UV light may effectively sanitize...

No evidence that mutations to SARS-CoV-2 increase transmissibility

An analysis of more than 15,000 SARS-CoV-2 genomes finds that mutations to the virus do not increase its transmissibility and are instead either neutral or detrimental to its spread. Since the emergence of SARS-CoV-2 in the human population at the end of 2019, the...

First human trial of SARS-CoV-2 vaccine: Initial results in

Researchers from China report the initial findings of the first human trial for a potential vaccine against SARS-CoV-2, the new coronavirus. The results are promising, suggesting that the vaccine is mostly safe and apparently effective. Share on PinterestThe initial...